GUNAR K ZAGARS to Time Factors
This is a "connection" page, showing publications GUNAR K ZAGARS has written about Time Factors.
Connection Strength
0.284
-
Mortality after cure of testicular seminoma. J Clin Oncol. 2004 Feb 15; 22(4):640-7.
Score: 0.022
-
Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):739-47.
Score: 0.021
-
Regarding Zagars and Pollack. Int J Radiat Oncol Biol Phys. 1998 Jul 01; 41(4):973-4.
Score: 0.015
-
Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology. 1998 Jun; 51(6):991-7.
Score: 0.015
-
Serum testosterone levels after external beam radiation for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1997 Aug 01; 39(1):85-9.
Score: 0.014
-
Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era. Cancer. 1997 Apr 01; 79(7):1370-80.
Score: 0.013
-
Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1996 Sep 01; 36(2):311-9.
Score: 0.013
-
Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1996 Mar 15; 34(5):983-94.
Score: 0.012
-
The source of pretreatment serum prostate-specific antigen in clinically localized prostate cancer--T, N, or M? Int J Radiat Oncol Biol Phys. 1995 Apr 30; 32(1):21-32.
Score: 0.012
-
The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1995 Jan 15; 31(2):237-45.
Score: 0.012
-
Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcome. J Urol. 1994 May; 151(5):1330-3.
Score: 0.011
-
The serum prostate-specific antigen level three months after radiotherapy for prostate cancer: an early indicator of response to treatment. Radiother Oncol. 1994 Feb; 30(2):121-7.
Score: 0.011
-
The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1993 Sep 01; 27(1):39-45.
Score: 0.010
-
Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy. Cancer. 1993 Jul 15; 72(2):538-48.
Score: 0.010
-
A commentary on dose escalation and bNED in prostate cancer. Int J Radiat Oncol Biol Phys. 2003 Mar 15; 55(4):1151; author reply 1151-2.
Score: 0.010
-
Mortality after cure of soft-tissue sarcoma treated with conservation surgery and radiotherapy. Cancer. 2008 Jul 15; 113(2):411-8.
Score: 0.007
-
Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):441-7.
Score: 0.007
-
Hodgkin's disease stages IA and IIA. A long-term follow-up study on the gains achieved by modern therapy. Cancer. 1985 Oct 15; 56(8):1905-12.
Score: 0.006
-
Laparotomy-staged IA versus IIA Hodgkin's disease. A comparative study with evaluation of prognostic factors for stage IIA disease. Cancer. 1985 Aug 15; 56(4):864-73.
Score: 0.006
-
Misonidazole and hemibody irradiation in the palliation of widespread metastases. Final report of an RTOG study. Am J Clin Oncol. 1985 Aug; 8(4):293-7.
Score: 0.006
-
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1461-7.
Score: 0.005
-
Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology. 2003 Oct; 62(4):707-13.
Score: 0.005
-
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x. Cancer. 2003 Apr 01; 97(7):1630-8.
Score: 0.005
-
Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys. 2002 Nov 01; 54(3):677-85.
Score: 0.005
-
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002 Aug 01; 53(5):1097-105.
Score: 0.005
-
Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy. Clin Cancer Res. 2002 May; 8(5):1148-54.
Score: 0.005
-
Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation. Int J Radiat Oncol Biol Phys. 1997 Jul 15; 38(5):1071-7.
Score: 0.003
-
Quiescence in R3327-G rat prostate tumors after androgen ablation. Cancer Res. 1997 Jun 15; 57(12):2493-500.
Score: 0.003
-
Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients. Cancer. 1994 Nov 15; 74(10):2819-27.
Score: 0.003
-
Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer. Urology. 1994 Nov; 44(5):711-8.
Score: 0.003
-
Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer. Cancer. 1994 Jul 15; 74(2):670-8.
Score: 0.003
-
Desmoid tumors: a 20-year radiotherapy experience. Int J Radiat Oncol Biol Phys. 1990 Jul; 19(1):37-40.
Score: 0.002
-
Hodgkin's disease: is there a price for successful treatment? A 25-year experience. Int J Radiat Oncol Biol Phys. 1986 Feb; 12(2):153-66.
Score: 0.002
-
Single-dose half-body irradiation for the palliation of multiple bone metastases from solid tumors: a preliminary report. Int J Radiat Oncol Biol Phys. 1981 Jun; 7(6):773-81.
Score: 0.001